227 related articles for article (PubMed ID: 34624411)
1. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies.
Beaufrère A; Caruso S; Calderaro J; Poté N; Bijot JC; Couchy G; Cauchy F; Vilgrain V; Zucman-Rossi J; Paradis V
J Hepatol; 2022 Feb; 76(2):343-352. PubMed ID: 34624411
[TBL] [Abstract][Full Text] [Related]
2. Contribution of virtual biopsy to the screening of microvascular invasion in hepatocellular carcinoma: A pilot study.
Poté N; Cauchy F; Albuquerque M; Cros J; Soubrane O; Bedossa P; Paradis V
Liver Int; 2018 Apr; 38(4):687-694. PubMed ID: 28872754
[TBL] [Abstract][Full Text] [Related]
3. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.
Xu X; Zhang HL; Liu QP; Sun SW; Zhang J; Zhu FP; Yang G; Yan X; Zhang YD; Liu XS
J Hepatol; 2019 Jun; 70(6):1133-1144. PubMed ID: 30876945
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.
Zhang H; Zhou Y; Li Y; Qin W; Zi Y; Liu Y; Qiu X; Xu H; Liao W; Huang Z
BMC Cancer; 2020 Feb; 20(1):132. PubMed ID: 32070301
[TBL] [Abstract][Full Text] [Related]
5. A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma.
Zhu Y; Xu D; Zhang Z; Dong J; Zhou Y; Zhang WW; Hong L; Zhu WW
Int J Surg; 2018 Sep; 57():45-53. PubMed ID: 30075291
[TBL] [Abstract][Full Text] [Related]
6. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
7. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
[TBL] [Abstract][Full Text] [Related]
8. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.
Shirabe K; Toshima T; Kimura K; Yamashita Y; Ikeda T; Ikegami T; Yoshizumi T; Abe K; Aishima S; Maehara Y
Liver Int; 2014 Jul; 34(6):937-41. PubMed ID: 24393295
[TBL] [Abstract][Full Text] [Related]
9. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
[TBL] [Abstract][Full Text] [Related]
10. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
[TBL] [Abstract][Full Text] [Related]
11. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
[TBL] [Abstract][Full Text] [Related]
13. Identification of DNA methylation signatures for hepatocellular carcinoma detection and microvascular invasion prediction.
Hao Y; Yang Q; He Q; Hu H; Weng Z; Su Z; Chen S; Peng S; Kuang M; Chen Z; Xu L
Eur J Med Res; 2022 Dec; 27(1):276. PubMed ID: 36464701
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma.
Wang L; Jin YX; Ji YZ; Mu Y; Zhang SC; Pan SY
World J Gastroenterol; 2020 Apr; 26(14):1647-1659. PubMed ID: 32327913
[TBL] [Abstract][Full Text] [Related]
15. A nomogram to predict microvascular invasion in early hepatocellular carcinoma.
Li H; Li T; Hu J; Liu J
J Cancer Res Ther; 2021 Jul; 17(3):652-657. PubMed ID: 34269295
[TBL] [Abstract][Full Text] [Related]
16. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
[TBL] [Abstract][Full Text] [Related]
17. Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors.
Shindoh J; Andreou A; Aloia TA; Zimmitti G; Lauwers GY; Laurent A; Nagorney DM; Belghiti J; Cherqui D; Poon RT; Kokudo N; Vauthey JN
Ann Surg Oncol; 2013 Apr; 20(4):1223-9. PubMed ID: 23179993
[TBL] [Abstract][Full Text] [Related]
18. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract][Full Text] [Related]
19. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
Banerjee S; Wang DS; Kim HJ; Sirlin CB; Chan MG; Korn RL; Rutman AM; Siripongsakun S; Lu D; Imanbayev G; Kuo MD
Hepatology; 2015 Sep; 62(3):792-800. PubMed ID: 25930992
[TBL] [Abstract][Full Text] [Related]
20. Accurate prediction of microvascular invasion occurrence and effective prognostic estimation for patients with hepatocellular carcinoma after radical surgical treatment.
Xiong Y; Cao P; Lei X; Tang W; Ding C; Qi S; Chen G
World J Surg Oncol; 2022 Sep; 20(1):328. PubMed ID: 36180867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
